Abstract
Backgroundanti-Programmed Death-1 (anti-PD-1) immunotherapy has shown promising manifestation in improving the survival rate of patients with advanced melanoma, with its efficacy closely linked to Programmed cell death-Ligand 1 (PD-L1) expression....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have